Skip to content
Disclosery

AIGH Capital Management LLC

Follow

13F filer, CIK 1835943, BALTIMORE, MD

AIGH Capital Management LLC reported $354,865,427 across 38 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-10-31. Its ten largest share positions make up 65.22% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-25-015641

Period
2025-09-30
Reported value
$355M
Holdings
38
Top 10 weight
65.22%
New
18
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SNDKnew+280,000$31.4M
MXLnew+1,107,504$17.8M
CSTLnew+707,287$16.1M
LUMNnew+2,550,000$15.6M
DAWNnew+1,520,492$10.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LPTHreduced-2,742,377-$21.7M
SCPHARMACEUTICALS INCexited-3,867,523-$14.7M
ELVAreduced-1,963,736-$11.6M
BLZEexited-1,809,096-$9.95M
VSTMexited-2,003,179-$8.31M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001214659-25-015641, largest first. % of portfolio is the value over $285,580,971, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SNDKSANDISK CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 280,000 shares 280,000$31.4M11%newTimeline
PSNLPERSONALIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,999,064 shares; 2024Q4: 3,799,064 shares; 2025Q1: 3,968,948 shares; 2025Q2: 3,723,958 shares; 2025Q3: 3,892,101 shares 3,892,101$25.4M8.89%+168,143Timeline
HUCKHUCKLEBERRY AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 751,583 shares; 2025Q2: 1,341,518 shares; 2025Q3: 1,341,518 shares 1,341,518$21.2M7.44%0Timeline
ARQARQ INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,817,078 shares; 2024Q4: 2,817,078 shares; 2025Q1: 2,770,278 shares; 2025Q2: 2,654,486 shares; 2025Q3: 2,579,486 shares 2,579,486$18.5M6.47%-75,000Timeline
MXLMAXLINEAR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,107,504 shares 1,107,504$17.8M6.24%newTimeline
LASRNLIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 600,103 shares; 2025Q3: 600,103 shares 600,103$17.8M6.23%0Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 707,287 shares 707,287$16.1M5.64%newTimeline
LUMNLUMEN TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,550,000 shares 2,550,000$15.6M5.46%newTimeline
ZVRAZEVRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 788,614 shares; 2025Q1: 1,438,109 shares; 2025Q2: 918,893 shares; 2025Q3: 1,231,932 shares 1,231,932$11.7M4.1%+313,039Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,520,492 shares 1,520,492$10.7M3.75%newTimeline
APPSDIGITAL TURBINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,490,140 shares; 2024Q4: not reported; 2025Q1: 430,849 shares; 2025Q2: not reported; 2025Q3: 1,523,068 shares 1,523,068$9.75M3.41%newTimeline
BKTIBK TECHNOLOGIES CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 282,772 shares; 2024Q4: 268,180 shares; 2025Q1: 268,180 shares; 2025Q2: not reported; 2025Q3: 99,009 shares 99,009$8.36M2.93%newTimeline
VPGVISHAY PRECISION GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 263,565 shares; 2025Q2: 423,484 shares; 2025Q3: 250,000 shares 250,000$8.01M2.81%-173,484Timeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,000,000 shares 3,000,000$7.95M2.78%newTimeline
LPTHLIGHTPATH TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,723,932 shares; 2024Q4: 3,723,932 shares; 2025Q1: 3,682,932 shares; 2025Q2: 3,642,377 shares; 2025Q3: 900,000 shares 900,000$7.14M2.5%-2,742,377Timeline
FENCFENNEC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 361,005 shares; 2025Q2: 452,400 shares; 2025Q3: 681,501 shares 681,501$6.38M2.23%+229,101Timeline
COYACOYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 649,427 shares; 2024Q4: 1,201,152 shares; 2025Q1: 1,183,780 shares; 2025Q2: 1,105,622 shares; 2025Q3: 1,105,622 shares 1,105,622$6.3M2.21%0Timeline
VELOVELO3D INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,719,874 shares 1,719,874$5.28M1.85%newTimeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 429,000 shares 429,000$5.05M1.77%newTimeline
AMBAAMBARELLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$4.13M1.44%newTimeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,454,545 shares 4,454,545$3.98M1.39%newTimeline
PYPDPOLYPID LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 679,668 shares; 2024Q4: 827,867 shares; 2025Q1: 940,381 shares; 2025Q2: 1,194,108 shares; 2025Q3: 1,065,128 shares 1,065,128$3.55M1.24%-128,980Timeline
RNXTRENOVORX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,467,275 shares; 2025Q2: 3,467,275 shares; 2025Q3: 2,615,193 shares 2,615,193$3.32M1.16%-852,082Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,000,000 shares 1,000,000$3.23M1.13%newTimeline
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,510,442 shares; 2024Q4: 3,074,675 shares; 2025Q1: 3,381,415 shares; 2025Q2: 3,451,025 shares; 2025Q3: 3,165,128 shares 3,165,128$2.82M0.99%-285,897Timeline
VUZIVUZIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 898,648 shares 898,648$2.81M0.98%newTimeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 521,083 shares; 2025Q1: 1,322,379 shares; 2025Q2: 1,128,497 shares; 2025Q3: 907,217 shares 907,217$2.7M0.95%-221,280Timeline
IPWRIDEAL PWR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 700,000 shares; 2024Q4: 823,315 shares; 2025Q1: 818,315 shares; 2025Q2: 668,623 shares; 2025Q3: 513,047 shares 513,047$2.58M0.9%-155,576Timeline
NRXSNEURAXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 19,869 shares; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares 400,000$1.23M0.43%0Timeline
ELVAELECTROVAYA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,447,626 shares; 2024Q4: 2,525,099 shares; 2025Q1: 2,262,323 shares; 2025Q2: 2,155,836 shares; 2025Q3: 192,100 shares 192,100$1.13M0.4%-1,963,736Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 198,500 shares 198,500$1.09M0.38%newTimeline
BFRIBIOFRONTERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 501,434 shares; 2024Q4: 811,097 shares; 2025Q1: 732,155 shares; 2025Q2: 974,525 shares; 2025Q3: 1,046,050 shares 1,046,050$1.03M0.36%+71,525Timeline
APREAPREA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 539,300 shares; 2024Q4: 539,300 shares; 2025Q1: 539,300 shares; 2025Q2: 539,300 shares; 2025Q3: 539,300 shares 539,300$795K0.28%0Timeline
SMTKSMARTKEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 134,687 shares; 2024Q4: 156,487 shares; 2025Q1: 291,681 shares; 2025Q2: 438,685 shares; 2025Q3: 425,277 shares 425,277$714K0.25%-13,408Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SEAGATE TECHNOLOGY HLDNGS PLSEAGATE TECHNOLOGY HLDNGS PL CALLcall12,470,132$37.9Mnew
GLWCORNING INC COMcall3,829,453$12.3M+3,654,453
MBLYMOBILEYE GLOBAL INC COMMON CLASS Acall4,423,008$11.3Mnew
ZVRAZEVRA THERAPEUTICS INC Stockcall3,221,110$7.65Mnew

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SCPHARMACEUTICALS INCSCPHARMACEUTICALS INC3,867,523$14.7Mshares
BLZEBACKBLAZE INC1,809,096$9.95Mshares
VSTMVERASTEM INC2,003,179$8.31Mshares
MYOMYOMO INC3,555,742$7.68Mshares
ALNTALLIENT INC200,000$7.26Mshares
HRTXHERON THERAPEUTICS INC3,009,257$6.23Mshares
THERATECHNOLOGIES INCTHERATECHNOLOGIES INC2,082,491$4.91Mshares
ANGOANGIODYNAMICS INC474,488$4.71Mshares
AMPGAMPLITECH GROUP INC905,453$1.92Mshares
KALAKALA BIO INC300,000$1.43Mshares
IDNINTELLICHECK MOBILISA INC154,174$831Kshares
BIOMX INCBIOMX INC1,566,944$705Kshares
KPRXKIORA PHARMACEUTICALS INC216,345$623Kshares
FKWLFRANKLIN WIRELESS CORP139,702$584Kshares
INABIN8BIO INC149,895$313Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-25-015641 base2025-10-31acceptance time not in the bulk data set